Profarma Distribuidora De Stock Return On Equity
| PFRM3 Stock | BRL 5.97 0.10 1.70% |
Profarma Distribuidora de fundamentals help investors to digest information that contributes to Profarma Distribuidora's financial success or failures. It also enables traders to predict the movement of Profarma Stock. The fundamental analysis module provides a way to measure Profarma Distribuidora's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Profarma Distribuidora stock.
Profarma |
Profarma Distribuidora de Company Return On Equity Analysis
Profarma Distribuidora's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Profarma Distribuidora Return On Equity | 0.0645 |
Most of Profarma Distribuidora's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Profarma Distribuidora de is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Profarma Distribuidora de has a Return On Equity of 0.0645. This is 100.27% lower than that of the Health Care Providers & Services sector and 99.13% lower than that of the Health Care industry. The return on equity for all Brazil stocks is 120.81% lower than that of the firm.
Profarma Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Profarma Distribuidora's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Profarma Distribuidora could also be used in its relative valuation, which is a method of valuing Profarma Distribuidora by comparing valuation metrics of similar companies.Profarma Distribuidora is regarded third in return on equity category among related companies.
Profarma Fundamentals
| Return On Equity | 0.0645 | |||
| Return On Asset | 0.0368 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 1.35 B | |||
| Shares Outstanding | 122.61 M | |||
| Shares Owned By Insiders | 66.17 % | |||
| Shares Owned By Institutions | 26.52 % | |||
| Price To Earning | (6.45) X | |||
| Price To Book | 0.35 X | |||
| Price To Sales | 0.06 X | |||
| Revenue | 6.41 B | |||
| Gross Profit | 907.57 M | |||
| EBITDA | 225.52 M | |||
| Net Income | 78.19 M | |||
| Cash And Equivalents | 139.49 M | |||
| Cash Per Share | 1.86 X | |||
| Total Debt | 740.04 M | |||
| Debt To Equity | 91.40 % | |||
| Current Ratio | 1.27 X | |||
| Book Value Per Share | 8.86 X | |||
| Cash Flow From Operations | 107.58 M | |||
| Earnings Per Share | 0.71 X | |||
| Target Price | 7.5 | |||
| Number Of Employees | 7.08 K | |||
| Beta | 1.14 | |||
| Market Capitalization | 399.71 M | |||
| Total Asset | 4.03 B | |||
| Retained Earnings | 92 M | |||
| Working Capital | 615 M | |||
| Current Asset | 1.57 B | |||
| Current Liabilities | 951 M | |||
| Z Score | 1.0 | |||
| Annual Yield | 0.05 % | |||
| Five Year Return | 1.29 % | |||
| Net Asset | 4.03 B | |||
| Last Dividend Paid | 0.27 |
About Profarma Distribuidora Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Profarma Distribuidora de's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Profarma Distribuidora using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Profarma Distribuidora de based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Profarma Distribuidora in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Profarma Distribuidora's short interest history, or implied volatility extrapolated from Profarma Distribuidora options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Profarma Distribuidora using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profarma Distribuidora de. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Profarma Distribuidora information on this page should be used as a complementary analysis to other Profarma Distribuidora's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Profarma Stock analysis
When running Profarma Distribuidora's price analysis, check to measure Profarma Distribuidora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profarma Distribuidora is operating at the current time. Most of Profarma Distribuidora's value examination focuses on studying past and present price action to predict the probability of Profarma Distribuidora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profarma Distribuidora's price. Additionally, you may evaluate how the addition of Profarma Distribuidora to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |